Biotechnology/pharma patent litigation in Brazil: an update on preliminary injunctions

August 4, 2022

This content is available on

Kluwer Patent Blog

Our partner Felipe Mesquita and attorney at law Carolina Mendes had their article “Biotechnology/pharma patent litigation in Brazil: an update on preliminary injunctions” published this Thursday (August 4), by the "Kluwer Patent Blog" website. It addresses recent decisions in litigation involving pharma patents that honor the protection of industrial property rights despite the public health challenges faced in Brazil. Full article at: http://patentblog.kluweriplaw.com/2022/08/04/biotechnology-pharma-patent-litigation-in-brazil-an-update-on-preliminary-injunctions/

-

Felipe Mesquita sócio e Carolina Mendes, advogada, tiveram seu artigo “Biotechnology/pharma patent litigation in Brazil: an update on preliminary injunctions” publicado hoje (4/8), no site "Kluwer Patent Blog". O artigo aborda recentes decisões em litígios envolvendo patentes farmacêuticas que prestigiam a proteção aos direitos de propriedade industrial apesar dos desafios de saúde pública enfrentados no Brasil. Leia o texto na íntegra: http://patentblog.kluweriplaw.com/2022/08/04/biotechnology-pharma-patent-litigation-in-brazil-an-update-on-preliminary-injunctions/

Previous Post

There is no previous post

Back to all posts

Next Post

There is no next post

Back to all posts

RECENT PUBLICATIONS

LINKEDIN FEED

Newsletter

Register your email and receive our updates

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

FOLLOW US ON SOCIAL MEDIA

Newsletter

Register your email and receive our updates-

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

FOLLOW US ON SOCIAL MEDIA